|
51 |
Systemic therapy of premenopausal patients with early stage hormone receptor-positive, HER2-negative breast cancer – controversies and standards in healthcare
Müller, Volkmar. - Freiburg : Universität, 2023
|
|
|
|
52 |
Systemic therapy of premenopausal patients with early stage hormone receptor-positive, HER2-negative breast cancer: controversies and standards in healthcare
Müller, Volkmar. - Augsburg : Universität Augsburg, 2023
|
|
|
|
53 |
Update breast cancer 2022 part 5: early stage breast cancer
Fehm, Tanja. - Augsburg : Universität Augsburg, 2023
|
|
|
|
54 |
Update breast cancer 2022 part 6: advanced-stage breast cancer
Lüftner, Diana. - Augsburg : Universität Augsburg, 2023
|
|
|
|
55 |
Update breast cancer 2023 Part 1: early stage breast cancer
Hartkopf, Andreas. - Augsburg : Universität Augsburg, 2023
|
|
|
|
56 |
Update breast cancer 2023 part 2: advanced-stage breast cancer
Lux, Michael Patrick. - Augsburg : Universität Augsburg, 2023
|
|
|
|
57 |
Update breast cancer 2023 part 3: expert opinions of early stage breast cancer therapies
Kolberg, Hans-Christian. - Augsburg : Universität Augsburg, 2023
|
|
|
58 |
Statement of the Uterus Commission of the Gynecological Oncology Working Group (AGO) on Surgical Therapy for Patients with Stage IA2–IIB1 Cervical Cancer
Enthalten in Geburtshilfe und Frauenheilkunde Bd. 83, 2023, Nr. 10: 1199-1204
|
|
|
|
59 |
Whole Exome Analysis to Select Targeted Therapies for Patients with Metastatic Breast Cancer – A Feasibility Study
Enthalten in Geburtshilfe und Frauenheilkunde Bd. 83, 2023, Nr. 09: 1138-1147
|
|
|
|
60 |
Update Breast Cancer 2023 Part 3 – Expert Opinions of Early Stage Breast Cancer Therapies
Enthalten in Geburtshilfe und Frauenheilkunde Bd. 83, 2023, Nr. 09: 1117-1126
|
|
Administration
